You just read:

aTyr Pharma Presents Additional Data for Resolaris™ Phase 1b/2 Trial in Adult Patients with Facioscapulohumeral Muscular Dystrophy at the 21st International Annual Congress of the World Muscle Society

News provided by

aTyr Pharma, Inc.

06 Oct, 2016, 09:00 ET